1. Home
  2. TIPT vs AGMB Comparison

TIPT vs AGMB Comparison

Compare TIPT & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiptree Inc.

TIPT

Tiptree Inc.

HOLD

Current Price

$17.76

Market Cap

663.9M

Sector

Finance

ML Signal

HOLD

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$13.81

Market Cap

562.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TIPT
AGMB
Founded
2007
2017
Country
United States
Belgium
Employees
N/A
62
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
663.9M
562.4M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
TIPT
AGMB
Price
$17.76
$13.81
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$32.00
AVG Volume (30 Days)
249.3K
98.9K
Earning Date
05-12-2026
04-23-2026
Dividend Yield
1.40%
N/A
EPS Growth
N/A
N/A
EPS
0.34
N/A
Revenue
$488,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.86
P/E Ratio
$50.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.49
$8.75
52 Week High
$27.38
$17.45

Technical Indicators

Market Signals
Indicator
TIPT
AGMB
Relative Strength Index (RSI) 50.84 67.36
Support Level $17.19 $9.54
Resistance Level $17.56 $14.19
Average True Range (ATR) 0.40 1.17
MACD -0.05 0.38
Stochastic Oscillator 19.21 87.43

Price Performance

Historical Comparison
TIPT
AGMB

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: